Literature DB >> 3040258

Interactions between a DNA-binding transcription factor (COUP) and a non-DNA binding factor (S300-II).

S Y Tsai, I Sagami, H Wang, M J Tsai, B W O'Malley.   

Abstract

We have identified previously two transcription factors, COUP (chicken ovalbumin upstream promoter) and S300-II, from HeLa cell nuclear extracts. In this paper, the purine base and the phosphate backbone contact sites for the COUP transcription factor were defined. These studies indicate that the COUP box transcription factor interacts with specific base residues in the major groove of the DNA helix. In addition, we have purified the S300-II factor over 100,000-fold. The polypeptide possessing functional transcriptional activity has been identified by SDS-PAGE followed by gel-slice elution and a renaturation assay. It is absolutely required for in vitro function of the ovalbumin promoter. In addition, S300-II stimulates transcription from the MMTV and lysozyme promoters. Kinetic studies probing the interaction of S300-II with COUP factor suggest that it may stabilize COUP-promoter complexes by slowing their rate of dissociation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040258     DOI: 10.1016/0092-8674(87)90328-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  48 in total

1.  Tissue-specific gene expression in the pituitary: the glycoprotein hormone alpha-subunit gene is regulated by a gonadotrope-specific protein.

Authors:  F Horn; J J Windle; K M Barnhart; P L Mellon
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

2.  Characterization of a novel T lymphocyte protein which binds to a site related to steroid/thyroid hormone receptor response elements in the negative regulatory sequence of the human immunodeficiency virus long terminal repeat.

Authors:  K Orchard; G Lang; M Collins; D Latchman
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

3.  Oestrogen facilitates the binding of ubiquitous and liver-enriched nuclear proteins to the apoVLDL II promoter in vivo.

Authors:  J Wijnholds; E Muller; G Ab
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

4.  Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat.

Authors:  J Hauber; B R Cullen
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  Chicken ovalbumin upstream promoter transcription factor binds to a negative regulatory region in the human immunodeficiency virus type 1 long terminal repeat.

Authors:  A J Cooney; S Y Tsai; B W O'Malley; M J Tsai
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

6.  Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.

Authors:  J C Blanco; I M Wang; S Y Tsai; M J Tsai; B W O'Malley; P W Jurutka; M R Haussler; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB.

Authors:  Ying Zhang; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.

Authors:  S Wang; Q Wang; B E Crute; I N Melnikova; S R Keller; N A Speck
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 9.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

10.  Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis.

Authors:  G E Muscat; S Rea; M Downes
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.